Advocacy Actions
Meeting with Prof. Hu Shanlian on Position Paper and Health Insurance Policy
European Chamber Pharmaceutical Working Group GA Coordinator met with Prof. Hu Shanlian, Senior Consultant of Shanghai Health Development Research Center
Read moreComments on CFDA's Administrative Measures of Drug Registration
Pharmaceutical Working Group comments on CFDA's Administrative Measures of Drug Registration
Read moreComments on SCLAO's Amendment of the Drug Administration Law of PRC (Draft for Comments)
Pharmaceutical Working Group Comments on SCLAO's Amendment of the Drug Administration Law of PRC (Draft for Comments)
Read moreComments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration
Comments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration
Read moreComments to NPC on Anti-Unfair Competition Law (Second Draft for Review)
On September 22, 2017, the European Chamber submitted feedback received from members regarding the call for comments on the second review draft of revision on Anti-Unfair Competition Law issued by the National People’s Congress (NPC).
Read moreComments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)
European Chamber Pharmaceutical Working Group comments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)
Read moreComments on CFDA's Announcement on Relevant Issues on Generics Quality and Efficacy Consistency Evaluation
European Chamber Comments on CFDA's Announcement on Relevant Issues on Generics Quality and Efficacy Consistency Evaluation
Read moreComments on CFDA's Inspection Guidelines on Generics Quality and Efficacy Consistency Evaluation
European Chamber Comments on CFDA's Inspection Guidelines on Generics Quality and Efficacy Consistency Evaluation
Read moreLetter to Medical Insurance Department of MOHRSS on Drug Renaming in NRDL
Letter to Medical Insurance Department of MOHRSS on Drug Renaming in NRDL
Read moreComments on CFDA's Announcement 52, 53, 54, 55 on Encouraging Innovation in Pharmaceutical and Medical Devices
European Chamber Pharmaceutical Working Group submitted comments on CFDA's Announcement No. 52, 53, 54, 55 on encouraging innovation in pharmaceutical and medical device.
Read more